Rachel Tiptanya Spann

Rachel Spann practices at Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare.

Rachel Spann's NPI, 1871054767, was assigned on March 25, 2019. Rachel Spann graduated from Tulane School of Medicine in 2019. Rachel Spann holds California license A177916.

Rachel Spann's primary practice is Sharp Chula Vista Medical Center, at 751 Medical Center Court, Chula Vista, CA 91911 in San Diego County. The practice phone is (619) 502-5800.

Rachel Spann's primary practice is Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare. Rachel Spann is also affiliated with Hillcrest Medical Center. The medical group on file is Vituity. Dmand AI also links Rachel Spann to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachel Spann practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Rachel Spann's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Rachel Spann is board certified in emergency medicine by the American Board of Emergency Medicine. Rachel Spann is licensed in California.

CMS data shows 618 Medicare services from Rachel Spann across 4 procedure codes in 2024, for 341 Medicare patients. Medicare paid $48,208 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 341 Medicare patients who saw Rachel Spann in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachel Spann's median patient age at 49, with 61% women.

In 2024, Rachel Spann wrote 353 Medicare Part D claims for 198 patients. 98% of them were for generic drugs. CMS names the drug for 233 of them, across 10 drugs with 11 or more claims each, at $1,546 in total drug cost. In 2023, CMS named 63 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Rachel Spann for performance year 2024, reported as part of a group. Rachel Spann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Rachel Spann in 2022. Rachel Spann's most frequent co-authors are Colleen J. Campbell, MD and Rachna A. Subramony, MD.

Rachel Spann graduated from Tulane School of Medicine in 2019.

Rachel Spann is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.